Genetic study for congenital hypothyroidism with normal thyroid location
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study uses advanced genetic testing to find the cause of permanent congenital hypothyroidism in children who have a thyroid gland in the normal position. It may help families understand why their child developed this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born in the Emilia-Romagna region of Italy between January 2003 and December 2023.
- Screened for congenital hypothyroidism and recalled for further testing at the Regional Centre in Bologna.
- Diagnosed with permanent congenital hypothyroidism and have a thyroid gland in its normal place (in situ).
- Followed at the same centre for at least 36 months since diagnosis.
- Parent or legal guardian agrees to participate by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of levothyroxine (a thyroid hormone medicine) to see which works better for newborns and children with congenital hypothyroidism (a condition where the thyroid gland doesn't work properly from birth). If your child was diagnosed early and lives in the Emilia-Romagna region of Italy, this trial may help find the best treatment.
This study looks at how congenital hypothyroidism (a condition where the thyroid gland doesn't work properly from birth) affects metabolism in children before puberty. It aims to understand if these children have a higher risk of metabolic problems, which could help with future care.
This study looks at how babies with primary congenital hypothyroidism (low thyroid hormone from birth) grow and develop after being treated. It helps doctors understand if treatment helps them reach normal milestones.
This study tests a more thorough screening approach for congenital hypothyroidism (a thyroid condition that can affect growth and brain development) in babies born very early. It aims to catch the condition sooner, so babies can get treatment that helps them develop normally.
This study looks at the long-term quality of life for people who were diagnosed with congenital hypothyroidism at birth and started treatment within the first month of life. It aims to understand how early treatment affects their health and well-being as they grow up.
This study tests a new way to adjust thyroid medication doses for children with either congenital hypothyroidism or Graves' disease. It aims to help find the right dose more easily and improve treatment outcomes.
Hear when a new Congenital Hypothyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.